CNMD
Conmed Corp. - Ordinary Shares
$50.00
-$0.01(-0.02%)
80
Overall
100
Value
60
Tech
--
Quality
Market Cap
$1.55B
Volume
461.10K
52W Range
$46.00 - $78.00
Target Price
$61.00
Order:
Income Statement
| Metric | Trend | Chart | 2015 Dec | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $719.2M | $763.5M | $796.4M | $859.6M | $955.1M | $862.5M | $1.0B | $1.0B | $1.2B | $1.3B | ||
| Total Revenue | $719.2M | $763.5M | $796.4M | $859.6M | $955.1M | $862.5M | $1.0B | $1.0B | $1.2B | $1.3B | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | $-337.5M | $-355.2M | $-365.4M | $-390.5M | $430.4M | $402.2M | $442.6M | $474.2M | $568.5M | $574.0M | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $381.7M | $408.3M | $431.0M | $469.1M | $524.7M | $460.3M | $568.0M | $571.2M | $676.2M | $733.0M | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $-330.5M | $-370.7M | $-384.1M | $-397.8M | $445.6M | $414.3M | $458.3M | $501.2M | $555.6M | $532.7M | ||
| Research & Development | $27.4M | $32.3M | $32.3M | $42.2M | $45.5M | $40.5M | $43.6M | $47.2M | $52.6M | $54.4M | ||
| Research Expense | $27.4M | $32.3M | $32.3M | $42.2M | $45.5M | $40.5M | $43.6M | $47.2M | $52.6M | $54.4M | ||
| Selling, General & Administrative | $303.1M | $338.4M | $351.8M | $355.6M | $400.1M | $373.8M | $414.8M | $454.0M | $503.0M | $478.3M | ||
| Selling & Marketing Expenses | $303.1M | $338.4M | $351.8M | $355.6M | -- | -- | -- | -- | $60.9M | $65.3M | ||
| General & Administrative Expenses | $-5.5M | $-6.0M | $-6.5M | $-8.7M | $400.1M | $373.8M | $414.8M | $454.0M | $503.0M | $478.3M | ||
| Salaries & Wages | $-7.5M | $-8.4M | $-8.5M | $-10.0M | $-2.8M | $-3.2M | $-3.9M | $-3.8M | $-4.0M | $-3.9M | ||
| Amortization | $-9.4M | $-17.2M | $-18.5M | $-23.2M | $626.3M | $628.1M | $627.7M | $815.4M | $809.0M | $806.9M | ||
| Other Operating Expenses | -- | $-1.6M | $-2.0M | $-1.0M | $-1.6M | -- | -- | $8.1M | $8.5M | $10.0M | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $51.2M | $37.7M | $46.9M | $71.3M | $79.1M | $46.0M | $109.7M | $70.1M | $120.6M | $200.3M | ||
| EBITDA | $95.1M | $90.0M | $105.5M | $9.5M | $158.0M | $118.3M | $179.3M | $32.5M | $198.5M | $277.9M | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | $6.0M | $15.4M | $18.2M | $20.7M | $42.7M | $44.1M | $35.5M | $28.9M | $39.8M | $37.3M | ||
| Net Non-Operating Interest Income/Expense | $-6.0M | $-15.4M | $-18.2M | $-20.7M | $-42.7M | $-44.1M | $-35.5M | $-28.9M | $-39.8M | $-37.3M | ||
| Other Income/Expense | -- | $2.9M | $-4.6M | $-903.5M | $5.2M | $355.0K | $1.1M | $-112.0M | $-14.9M | $-54.3M | ||
| Other Special Charges | -- | $-2.9M | $4.6M | $5.0M | $-5.2M | $-355.0K | $-1.1M | $-112.0M | $12.5M | $13.9M | ||
| SPECIAL ITEMS | ||||||||||||
| Restructring And Mn A Income | $-21.7M | $-9.7M | $-100.0K | $-10.4M | $-44.4M | -- | -- | -- | -- | -- | ||
| Special Income Charges | $21.7M | $13.5M | $9.9M | $15.1M | $39.6M | $-4.7M | $-3.3M | $-2.1M | $-1.7M | $-1.4M | ||
| Impairment of Capital Assets | -- | -- | $-4.5M | $-4.7M | $4.8M | $4.7M | $3.3M | $2.1M | $1.7M | $1.4M | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $51.2M | $34.7M | $46.9M | $71.3M | $73.9M | $45.7M | $108.6M | $-42.0M | $120.6M | $200.3M | ||
| Pre-Tax Income | $45.1M | $19.4M | $28.7M | $50.7M | $31.2M | $1.6M | $73.1M | $-70.9M | $80.8M | $163.0M | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $14.6M | $4.7M | $-26.8M | $9.8M | $2.6M | $-7.9M | $10.6M | $9.7M | $16.4M | $30.6M | ||
| NET INCOME | ||||||||||||
| Net Income | $30.5M | $14.7M | $55.5M | $40.9M | $28.6M | $9.5M | $62.5M | $-80.6M | $64.5M | $132.4M | ||
| Net Income (Continuing Operations) | $30.5M | $14.7M | $55.5M | $40.9M | $28.6M | $9.5M | $62.5M | $-80.6M | $64.5M | $132.4M | ||
| Net Income (Discontinued Operations) | $30.5M | $14.7M | $55.5M | $40.9M | $28.6M | $9.5M | $62.5M | $-80.6M | $64.5M | $132.4M | ||
| Net Income (Common Stockholders) | $30.5M | $14.7M | $55.5M | $40.9M | $28.6M | $9.5M | $62.5M | $-80.6M | $64.5M | $132.4M | ||
| Normalized Income | -- | -- | -- | -- | -- | -- | -- | -- | -- | $122.4M | ||
| TOTALS | ||||||||||||
| Total Expenses | $-668.0M | $-725.8M | $-749.5M | $-788.3M | $876.0M | $816.4M | $900.9M | $975.4M | $1.1B | $1.1B | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $27.7M | $27.8M | $27.9M | $28.1M | $28.3M | $28.6M | $29.2M | $30.0M | $30.7M | $30.8M | ||
| Average Shares Outstanding (Diluted) | $27.9M | $28.0M | $28.2M | $28.9M | $29.5M | $29.5M | $32.2M | $30.0M | $31.5M | $31.1M | ||
| Shares Outstanding | $27.7M | $27.8M | $28.0M | $28.2M | $28.5M | $28.9M | $29.4M | $31.0M | $30.8M | $30.9M | ||
| Basic EPS | $1.1 | $0.53 | $1.99 | $1.45 | $1.01 | $0.33 | $2.14 | $-2.68 | $2.1 | $4.29 | ||
| Basic EPS (Continuing Operations) | -- | -- | -- | -- | $1.01 | $0.33 | $2.14 | $-2.68 | $2.1 | $4.29 | ||
| Diluted EPS | $1.09 | $0.52 | $1.97 | $1.41 | $0.97 | $0.32 | $1.94 | $-2.68 | $2.04 | $4.25 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | -- | $0.97 | $0.32 | $1.94 | $-2.68 | $2.04 | $4.25 | ||
| Dividend Per Share | $0.80 | $0.80 | $0.80 | $0.80 | $0.80 | $0.80 | $0.80 | $0.80 | $0.80 | $0.80 | ||
| OTHER METRICS | ||||||||||||
| Commission Expenses | -- | -- | $-8.2M | -- | -- | -- | -- | -- | -- | -- | ||
| Fees | -- | $2.7M | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Gain On Sale Of P P E | -- | $1.9M | -- | -- | -- | -- | -- | $-5.5M | -- | -- | ||
| Marketing Expense | -- | -- | -- | -- | -- | -- | -- | -- | $60.9M | $65.3M | ||
| Non Recurring Operation Expense | -- | $-3.8M | $-5.3M | -- | -- | -- | -- | -- | -- | -- | ||
| Other Gand A | $-5.5M | $-6.0M | $-6.5M | $-8.7M | $400.1M | $373.8M | $414.8M | $454.0M | $503.0M | $478.3M | ||
| Other Impairment Of Capital Assets | -- | -- | -- | -- | $312.0K | -- | -- | -- | -- | $606.0K | ||
| Other Write Down | -- | -- | -- | -- | -- | -- | $899.0K | $3.4M | -- | -- | ||
| Rent And Landing Fees | $-5.5M | $-6.0M | $-6.5M | $-8.7M | -- | -- | -- | -- | -- | -- | ||
| Selling Expense | $303.1M | $338.4M | $351.8M | $355.6M | -- | -- | -- | -- | -- | -- | ||
| Restruct | $-21.7M | $-9.7M | $-100.0K | $-10.4M | $-44.4M | -- | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CNMD | $50.00 | -0.0% | 461.10K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Conmed Corp. - Ordinary Shares Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW